|
A more recent version of this article appeared on November 1, 2007
Papers In Press, published online ahead of print August 10, 2007
J. Lipid Res., doi:10.1194/jlr.M700325-JLR200
Submitted on July 19, 2007
Revised on August 3, 2007
Accepted on August 9, 2007
Intracellular PAF catabolism by PAF acetylhydrolase counteracts continual PAF synthesis
Jiawei Chen, Lili Yang, Jason M. Foulks, Andrew S. Weyrich, Guy A. Zimmerman, Gopal K. Marathe, and Thomas M. McIntyre
Cell Biology, Cleveland Clinic, Cleveland, OH 44195
Corresponding Author: mcintyt{at}ccf.org
Stimulated inflammatory cells synthesize platelet-activating factor (PAF), but lysates of these cells show little enhancement in PAF synthase activity. We show human neutrophils contain intracellular plasma PAF acetylhydrolase (PLA2G7), an enzyme normally secreted by monocytes. The esterase inhibitors methyl arachidonoyl fluorophosphonate (MAFP), its linoleoyl homolog, and Pefabloc inhibit plasma PAF acetylhydrolase. All these inhibitors induced PAF accumulation by quiescent neutrophils and monocytes that was equivalent to agonist stimulation. Agonist stimulation after esterase inhibition did not further increase PAF accumulation. PAF acetylhydrolase activity in intact neutrophils was reduced, but not abolished, by agonist stimulation. Erythrocytes, which do not participate in the acute inflammatory response, inexplicably express the type I PAF acetylhydrolase whose only known substrate is PAF. Inhibition of this enzyme by MAFP caused PAF accumulation by erythrocytes, which was hemolytic in the absence of PAF acetylhydrolase activity. We propose that PAF is continuously synthesized by a non-selective acyltransferase activity(ies) found even in non-inflammatory cells as a component of membrane remodeling, which is then selectively and continually degraded by intracellular PAF acetylhydrolase activity to modulate PAF production.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. M. Foulks, G. K. Marathe, N. Michetti, D. M. Stafforini, G. A. Zimmerman, T. M. McIntyre, and A. S. Weyrich
PAF-acetylhydrolase expressed during megakaryocyte differentiation inactivates PAF-like lipids
Blood,
June 25, 2009;
113(26):
6699 - 6706.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. McIntyre, S. M. Prescott, and D. M. Stafforini
The emerging roles of PAF acetylhydrolase
J. Lipid Res.,
April 1, 2009;
50(Supplement):
S255 - S259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Ryan, C. S. Harris, C. L. Carswell, J. E. Baenziger, and S. A. L. Bennett
Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons
J. Lipid Res.,
October 1, 2008;
49(10):
2250 - 2258.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|